E. Cure Et Al. , "Severe hypocalcemia associated with zoledronic acid treatment in a patient with a risk of fracture due to drug-induced osteopenia," MINERVA ENDOCRINOLOGICA , vol.38, no.2, pp.217-218, 2013
Cure, E. Et Al. 2013. Severe hypocalcemia associated with zoledronic acid treatment in a patient with a risk of fracture due to drug-induced osteopenia. MINERVA ENDOCRINOLOGICA , vol.38, no.2 , 217-218.
Cure, E., YUCE, S., & Cure, M., (2013). Severe hypocalcemia associated with zoledronic acid treatment in a patient with a risk of fracture due to drug-induced osteopenia. MINERVA ENDOCRINOLOGICA , vol.38, no.2, 217-218.
Cure, ERKAN, S. YUCE, And MEDİNE CUMHUR CÜRE. "Severe hypocalcemia associated with zoledronic acid treatment in a patient with a risk of fracture due to drug-induced osteopenia," MINERVA ENDOCRINOLOGICA , vol.38, no.2, 217-218, 2013
Cure, ERKAN Et Al. "Severe hypocalcemia associated with zoledronic acid treatment in a patient with a risk of fracture due to drug-induced osteopenia." MINERVA ENDOCRINOLOGICA , vol.38, no.2, pp.217-218, 2013
Cure, E. YUCE, S. And Cure, M. (2013) . "Severe hypocalcemia associated with zoledronic acid treatment in a patient with a risk of fracture due to drug-induced osteopenia." MINERVA ENDOCRINOLOGICA , vol.38, no.2, pp.217-218.
@article{article, author={ERKAN CÜRE Et Al. }, title={Severe hypocalcemia associated with zoledronic acid treatment in a patient with a risk of fracture due to drug-induced osteopenia}, journal={MINERVA ENDOCRINOLOGICA}, year=2013, pages={217-218} }